New Delhi: The Brazilian health regulator on Monday scrapped the approval application of Bharat Biotech’s Covaxin setting the stage for the termination of a multi-million dollar deal Bharat Biotech had with Brazil to seek Covaxin doses to the South American nation. The US $324 million deal was signed in February. TNS
Most Read In 24 Hours
Don't MissView All
Punjab Police issue lookout circular, non-bailable warrant against Amritpal Singh
Several pictures of Amritpal Singh in different attires rele...
Supreme Court agrees to constitute special bench to hear Bilkis Bano's plea against remission to convicts in gang-rape case
A bench of Chief Justice DY Chandrachud and justices PS Nara...
Raja Warring writes to Punjab DGP, flags concern about youths being rounded up and labelled Amritpal supporters
Says while the Punjab Congress doesn’t support any leniency ...